Citadel Advisors’s Arotech Corporation ARTX Stock Holding History

Citadel Advisors’s Portfolio ARTX Stock Details ARTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,400	Closed	-$13K	–	9417
2015 Q2	$13K	Buy	5,400 +2,300	+74%	+$6.29K	﹤0.01%	8337
2015 Q1	$10K	Buy	3,100 +2,300	+288%	+$5.97K	﹤0.01%	8199
2014 Q4	$2K	Buy	+800	New	+$2.08K	﹤0.01%	8385
2014 Q3	–	Sell	-1,100	Closed	-$5K	–	8570
2014 Q2	$5K	Buy	+1,100	New	+$4.69K	﹤0.01%	7735

Citadel Advisors's ARTX Position: Q4 2019 in Review

Citadel Advisors sold out of Arotech Corporation (ARTX) in Q4 2019, closing a stake of 25,754 shares — an estimated $76K sold.

Citadel Advisors first reported a position in ARTX in Q3 2013 and held it in 17 quarters. The position peaked at $178K in Q4 2017. 0 funds tracked by Wall St. Rank hold ARTX as of Q4 2019.

Citadel Advisors reported no remaining Arotech Corporation position as of Q4 2019 after selling out during the quarter.
Citadel Advisors sold 25,754 Arotech Corporation shares in Q4 2019, an estimated $76K.
Citadel Advisors first reported a position in Arotech Corporation in Q3 2013 and held it in 17 quarters.
Citadel Advisors's Arotech Corporation position peaked at $178K in Q4 2017.
0 funds tracked by Wall St. Rank held Arotech Corporation as of Q4 2019.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.